カテゴリー： QYResearch, 世界

世界の上衣細胞腫薬市場 2019年

【英語タイトル】Global Ependymoma Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07393）・商品コード：DATA909X07393
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、上衣細胞腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アベマシクリブ、インドキシモド、アファチニブジマレエート、アリセルチブ、G-207、その他に、用途別には、クリニック、病院、その他にセグメント区分し、上衣細胞腫薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・上衣細胞腫薬の世界市場概要
・上衣細胞腫薬の製造コスト構成分析
・上衣細胞腫薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・上衣細胞腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・上衣細胞腫薬のセグメント分析（種類別）
（アベマシクリブ、インドキシモド、アファチニブジマレエート、アリセルチブ、G-207、その他）
・上衣細胞腫薬のセグメント分析（用途別）
（クリニック、病院、その他）
・上衣細胞腫薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Cavion LLC、Advantagene Inc、Amgen Inc、Celgene Corp、Eli Lilly and Company、Millennium Pharmaceuticals Inc、NewLink Genetics Corp、Ono Pharmaceutical Co Ltd、）
・上衣細胞腫薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Ependymoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Ependymoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ependymoma Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ependymoma Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ependymoma Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Cavion LLC
Advantagene Inc
Amgen Inc
Celgene Corp
Eli Lilly and Company
Millennium Pharmaceuticals Inc
NewLink Genetics Corp
Ono Pharmaceutical Co Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Abemaciclib
Indoximod
Afatinib Dimaleate
Alisertib
G-207
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Ependymoma Drug
1.1 Definition of Ependymoma Drug
1.2 Ependymoma Drug Segment by Type
1.2.1 Global Ependymoma Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Abemaciclib
1.2.3 Indoximod
1.2.4 Afatinib Dimaleate
1.2.5 Alisertib
1.2.6 G-207
1.2.7 Others
1.3 Ependymoma Drug Segment by Applications
1.3.1 Global Ependymoma Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Ependymoma Drug Overall Market
1.4.1 Global Ependymoma Drug Revenue (2014-2025)
1.4.2 Global Ependymoma Drug Production (2014-2025)
1.4.3 North America Ependymoma Drug Status and Prospect (2014-2025)
1.4.4 Europe Ependymoma Drug Status and Prospect (2014-2025)
1.4.5 China Ependymoma Drug Status and Prospect (2014-2025)
1.4.6 Japan Ependymoma Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ependymoma Drug Status and Prospect (2014-2025)
1.4.8 India Ependymoma Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ependymoma Drug
2.3 Manufacturing Process Analysis of Ependymoma Drug
2.4 Industry Chain Structure of Ependymoma Drug

3 Development and Manufacturing Plants Analysis of Ependymoma Drug
3.1 Capacity and Commercial Production Date
3.2 Global Ependymoma Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ependymoma Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Ependymoma Drug Production and Capacity Analysis
4.2 Ependymoma Drug Revenue Analysis
4.3 Ependymoma Drug Price Analysis
4.4 Market Concentration Degree

5 Ependymoma Drug Regional Market Analysis
5.1 Ependymoma Drug Production by Regions
5.1.1 Global Ependymoma Drug Production by Regions
5.1.2 Global Ependymoma Drug Revenue by Regions
5.2 Ependymoma Drug Consumption by Regions
5.3 North America Ependymoma Drug Market Analysis
5.3.1 North America Ependymoma Drug Production
5.3.2 North America Ependymoma Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ependymoma Drug Import and Export
5.4 Europe Ependymoma Drug Market Analysis
5.4.1 Europe Ependymoma Drug Production
5.4.2 Europe Ependymoma Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ependymoma Drug Import and Export
5.5 China Ependymoma Drug Market Analysis
5.5.1 China Ependymoma Drug Production
5.5.2 China Ependymoma Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ependymoma Drug Import and Export
5.6 Japan Ependymoma Drug Market Analysis
5.6.1 Japan Ependymoma Drug Production
5.6.2 Japan Ependymoma Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ependymoma Drug Import and Export
5.7 Southeast Asia Ependymoma Drug Market Analysis
5.7.1 Southeast Asia Ependymoma Drug Production
5.7.2 Southeast Asia Ependymoma Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ependymoma Drug Import and Export
5.8 India Ependymoma Drug Market Analysis
5.8.1 India Ependymoma Drug Production
5.8.2 India Ependymoma Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ependymoma Drug Import and Export

6 Ependymoma Drug Segment Market Analysis (by Type)
6.1 Global Ependymoma Drug Production by Type
6.2 Global Ependymoma Drug Revenue by Type
6.3 Ependymoma Drug Price by Type

7 Ependymoma Drug Segment Market Analysis (by Application)
7.1 Global Ependymoma Drug Consumption by Application
7.2 Global Ependymoma Drug Consumption Market Share by Application (2014-2019)

8 Ependymoma Drug Major Manufacturers Analysis
8.1 Boehringer Ingelheim GmbH
8.1.1 Boehringer Ingelheim GmbH Ependymoma Drug Production Sites and Area Served
8.1.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
8.1.3 Boehringer Ingelheim GmbH Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company Ependymoma Drug Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cavion LLC
8.3.1 Cavion LLC Ependymoma Drug Production Sites and Area Served
8.3.2 Cavion LLC Product Introduction, Application and Specification
8.3.3 Cavion LLC Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Advantagene Inc
8.4.1 Advantagene Inc Ependymoma Drug Production Sites and Area Served
8.4.2 Advantagene Inc Product Introduction, Application and Specification
8.4.3 Advantagene Inc Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Amgen Inc
8.5.1 Amgen Inc Ependymoma Drug Production Sites and Area Served
8.5.2 Amgen Inc Product Introduction, Application and Specification
8.5.3 Amgen Inc Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Celgene Corp
8.6.1 Celgene Corp Ependymoma Drug Production Sites and Area Served
8.6.2 Celgene Corp Product Introduction, Application and Specification
8.6.3 Celgene Corp Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Eli Lilly and Company
8.7.1 Eli Lilly and Company Ependymoma Drug Production Sites and Area Served
8.7.2 Eli Lilly and Company Product Introduction, Application and Specification
8.7.3 Eli Lilly and Company Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Millennium Pharmaceuticals Inc
8.8.1 Millennium Pharmaceuticals Inc Ependymoma Drug Production Sites and Area Served
8.8.2 Millennium Pharmaceuticals Inc Product Introduction, Application and Specification
8.8.3 Millennium Pharmaceuticals Inc Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 NewLink Genetics Corp
8.9.1 NewLink Genetics Corp Ependymoma Drug Production Sites and Area Served
8.9.2 NewLink Genetics Corp Product Introduction, Application and Specification
8.9.3 NewLink Genetics Corp Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Ono Pharmaceutical Co Ltd
8.10.1 Ono Pharmaceutical Co Ltd Ependymoma Drug Production Sites and Area Served
8.10.2 Ono Pharmaceutical Co Ltd Product Introduction, Application and Specification
8.10.3 Ono Pharmaceutical Co Ltd Ependymoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Ependymoma Drug Market
9.1 Global Ependymoma Drug Market Trend Analysis
9.1.1 Global Ependymoma Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Ependymoma Drug Regional Market Trend
9.2.1 North America Ependymoma Drug Forecast 2019-2025
9.2.2 Europe Ependymoma Drug Forecast 2019-2025
9.2.3 China Ependymoma Drug Forecast 2019-2025
9.2.4 Japan Ependymoma Drug Forecast 2019-2025
9.2.5 Southeast Asia Ependymoma Drug Forecast 2019-2025
9.2.6 India Ependymoma Drug Forecast 2019-2025
9.3 Ependymoma Drug Market Trend (Product Type)
9.4 Ependymoma Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ependymoma Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Ependymoma Drug
Table Global Ependymoma Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Ependymoma Drug Production Market Share by Types in 2018
Figure Abemaciclib Product Picture
Figure Indoximod Product Picture
Figure Afatinib Dimaleate Product Picture
Figure Alisertib Product Picture
Figure G-207 Product Picture
Figure Others Product Picture
Table Global Ependymoma Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Ependymoma Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Ependymoma Drug Revenue (Million USD) (2014-2025)
Figure Global Ependymoma Drug Production (K Pcs) (2014-2025)
Figure North America Ependymoma Drug Market Size (Million USD) (2014-2025)
Figure Europe Ependymoma Drug Market Size (Million USD) (2014-2025)
Figure China Ependymoma Drug Market Size (Million USD) (2014-2025)
Figure Japan Ependymoma Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ependymoma Drug Market Size (Million USD) (2014-2025)
Figure India Ependymoma Drug Market Size (Million USD) (2014-2025)
Table Ependymoma Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ependymoma Drug in 2018
Figure Manufacturing Process Analysis of Ependymoma Drug
Figure Industry Chain Structure of Ependymoma Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ependymoma Drug Manufacturing Plants Distribution
Table Ependymoma Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ependymoma Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Ependymoma Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Ependymoma Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Ependymoma Drug Production Share by Manufacturers in 2018
Table Ependymoma Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ependymoma Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ependymoma Drug Revenue Share by Manufacturers in 2018
Table Ependymoma Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ependymoma Drug Production by Regions 2014-2019 (K Pcs)
Table Global Ependymoma Drug Production Market Share by Regions 2014-2019
Figure Global Ependymoma Drug Production Market Share by Regions in 2018
Table Global Ependymoma Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Ependymoma Drug Revenue Market Share by Regions 2014-2019
Figure Global Ependymoma Drug Revenue Market Share by Regions in 2018
Table Global Ependymoma Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Ependymoma Drug Consumption Market Share by Regions 2014-2019
Figure North America Ependymoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Ependymoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ependymoma Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Ependymoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Ependymoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ependymoma Drug Production, Consumption Import and Export (K Pcs)
Figure China Ependymoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Ependymoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Ependymoma Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Ependymoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Ependymoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ependymoma Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Ependymoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Ependymoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ependymoma Drug Production, Consumption Import and Export (K Pcs)
Figure India Ependymoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Ependymoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Ependymoma Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Ependymoma Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ependymoma Drug Market Share by Application (2014-2019)
Table Boehringer Ingelheim GmbH Ependymoma Drug Production Sites and Area Served
Table Boehringer Ingelheim GmbH Ependymoma Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim GmbH Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim GmbH Ependymoma Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim GmbH Ependymoma Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim GmbH Ependymoma Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim GmbH Ependymoma Drug Main Business and Markets Served
Table Bristol-Myers Squibb Company Ependymoma Drug Production Sites and Area Served
Table Bristol-Myers Squibb Company Ependymoma Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Ependymoma Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Ependymoma Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Ependymoma Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Ependymoma Drug Main Business and Markets Served
Table Cavion LLC Ependymoma Drug Production Sites and Area Served
Table Cavion LLC Ependymoma Drug Product Introduction, Application and Specification
Table Cavion LLC Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cavion LLC Ependymoma Drug Production Growth Rate (2014-2019)
Table Cavion LLC Ependymoma Drug Production Market Share (2014-2019)
Figure Cavion LLC Ependymoma Drug Revenue Market Share (2014-2019)
Table Cavion LLC Ependymoma Drug Main Business and Markets Served
Table Advantagene Inc Ependymoma Drug Production Sites and Area Served
Table Advantagene Inc Ependymoma Drug Product Introduction, Application and Specification
Table Advantagene Inc Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Advantagene Inc Ependymoma Drug Production Growth Rate (2014-2019)
Table Advantagene Inc Ependymoma Drug Production Market Share (2014-2019)
Figure Advantagene Inc Ependymoma Drug Revenue Market Share (2014-2019)
Table Advantagene Inc Ependymoma Drug Main Business and Markets Served
Table Amgen Inc Ependymoma Drug Production Sites and Area Served
Table Amgen Inc Ependymoma Drug Product Introduction, Application and Specification
Table Amgen Inc Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc Ependymoma Drug Production Growth Rate (2014-2019)
Table Amgen Inc Ependymoma Drug Production Market Share (2014-2019)
Figure Amgen Inc Ependymoma Drug Revenue Market Share (2014-2019)
Table Amgen Inc Ependymoma Drug Main Business and Markets Served
Table Celgene Corp Ependymoma Drug Production Sites and Area Served
Table Celgene Corp Ependymoma Drug Product Introduction, Application and Specification
Table Celgene Corp Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corp Ependymoma Drug Production Growth Rate (2014-2019)
Table Celgene Corp Ependymoma Drug Production Market Share (2014-2019)
Figure Celgene Corp Ependymoma Drug Revenue Market Share (2014-2019)
Table Celgene Corp Ependymoma Drug Main Business and Markets Served
Table Eli Lilly and Company Ependymoma Drug Production Sites and Area Served
Table Eli Lilly and Company Ependymoma Drug Product Introduction, Application and Specification
Table Eli Lilly and Company Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Ependymoma Drug Production Growth Rate (2014-2019)
Table Eli Lilly and Company Ependymoma Drug Production Market Share (2014-2019)
Figure Eli Lilly and Company Ependymoma Drug Revenue Market Share (2014-2019)
Table Eli Lilly and Company Ependymoma Drug Main Business and Markets Served
Table Millennium Pharmaceuticals Inc Ependymoma Drug Production Sites and Area Served
Table Millennium Pharmaceuticals Inc Ependymoma Drug Product Introduction, Application and Specification
Table Millennium Pharmaceuticals Inc Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Millennium Pharmaceuticals Inc Ependymoma Drug Production Growth Rate (2014-2019)
Table Millennium Pharmaceuticals Inc Ependymoma Drug Production Market Share (2014-2019)
Figure Millennium Pharmaceuticals Inc Ependymoma Drug Revenue Market Share (2014-2019)
Table Millennium Pharmaceuticals Inc Ependymoma Drug Main Business and Markets Served
Table NewLink Genetics Corp Ependymoma Drug Production Sites and Area Served
Table NewLink Genetics Corp Ependymoma Drug Product Introduction, Application and Specification
Table NewLink Genetics Corp Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table NewLink Genetics Corp Ependymoma Drug Production Growth Rate (2014-2019)
Table NewLink Genetics Corp Ependymoma Drug Production Market Share (2014-2019)
Figure NewLink Genetics Corp Ependymoma Drug Revenue Market Share (2014-2019)
Table NewLink Genetics Corp Ependymoma Drug Main Business and Markets Served
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Production Sites and Area Served
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Product Introduction, Application and Specification
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Production Growth Rate (2014-2019)
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Production Market Share (2014-2019)
Figure Ono Pharmaceutical Co Ltd Ependymoma Drug Revenue Market Share (2014-2019)
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Main Business and Markets Served
Figure Global Ependymoma Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Ependymoma Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ependymoma Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Ependymoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Ependymoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ependymoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Ependymoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ependymoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Ependymoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ependymoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Ependymoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ependymoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Ependymoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ependymoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Ependymoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Ependymoma Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Ependymoma Drug by Application (2019-2025)
Table Ependymoma Drug Distributors List
Table Ependymoma Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Cavion LLC、Advantagene Inc、Amgen Inc、Celgene Corp、Eli Lilly and Company、Millennium Pharmaceuticals Inc、NewLink Genetics Corp、Ono Pharmaceutical Co Ltd、

★調査レポート[世界の上衣細胞腫薬市場 2019年] (コード：DATA909X07393)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の上衣細胞腫薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の退形成性乏突起膠腫薬市場 2019年
    DATA909X03539 / QYResearch / 2019年11月15日 / ※本調査レポートは、退形成性乏突起膠腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他に、用途別には、病院、クリニック、研究センターにセグメント区分し、退形成性乏突起膠腫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・退形成性乏突起膠腫薬の世界市場概要 ・退形成性乏突起膠腫薬の製造コスト構成分析 ・退形成性乏突起膠腫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・退形成性乏突起膠腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・退形成性乏突起膠腫薬のセグメント分析（種類別） （CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他）...The global Anaplastic Oligoastrocytoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anaplastic Oligoastrocytoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anaplastic Oligoastrocytoma Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anaplastic Oligoastrocytoma Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の内分泌系薬物市場 2019年
    DATA909X07314 / QYResearch / 2019年11月15日 / ※本調査レポートは、内分泌系薬物の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、糖尿病治療薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他に、用途別には、病院、診療所、医療センター、その他にセグメント区分し、内分泌系薬物の世界市場を分析しました。 ・エグゼクティブ・サマリー ・内分泌系薬物の世界市場概要 ・内分泌系薬物の製造コスト構成分析 ・内分泌系薬物の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・内分泌系薬物の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・内分泌系薬物のセグメント分析（種類別） （糖尿病治療薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他）...The global Endocrine System Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Endocrine System Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endocrine System Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Endocrine System Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆